Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Pancreatic Surgery (NEUPRODEX)
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Cognition disorders; Delirium; Postoperative complications
- Focus Therapeutic Use
- Acronyms Neuprodex
- 16 Mar 2018 Planned number of patients changed from 87 to 77.
- 10 Jun 2017 Biomarkers information updated
- 21 Mar 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2018.